News
-
New App Adjusts Brain Stimulators For Parkinson’s Patients
(May 15, 2017) – An iPod app is helping patients with Parkinson’s disease who have had Deep Brain Stimulation (DBS). The app connects to his electrode generator via a secure Bluetooth link and can be used to help reduce tremors. Read more…
-
Survey Examines Social Support in Parkinson’s Disease from the Patient’s Perspective
KINGSTON, N.J., May 15, 2017/ — The Parkinson Alliance conducted its 26th survey-based research, entitled Social Support and Parkinson’s Disease: The Patient’s Perspective. Individuals with Parkinson’s disease (PD) are confronted with debilitating sym …
-
Medtronic Brain Therapies Sponsors Parkinson’s Unity Walk
(April 20, 2017) Medtronic announced its sponsorship of the 23rd Parkinson’s Unity Walk which will be held on April 22, 2017. http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2263159…
-
NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinson’s Unity Walk
(April 20, 2017) – NeuroDerm, a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that the company’s CEO, Oded S. Lieberman, PhD, will ring The Nasdaq Stock …
-
Acorda Announces Long-Term Safety Data for CVT-301
(March 29, 2017) – Acorda Therapeutics, Inc. today announced results from two ongoing, long-term safety studies of CVT-301 in people with Parkinson’s that showed no differences in pulmonary function between the group receiving CVT-301 and an obse …
-
JFK Medical Center Offers Parkinson’s Disease Educational Seminar 4.5.17
(March 26, 2017) – JFK Medical Center in Edison, NJ is offering a free Parkinson’s disease educational seminar on Wednesday, April 5, 2017. The program, “Fighting Back” will feature Dr. Alice Lazzarini, internationally recognize …
-
FDA Approves Xadago to Treat Parkinson’s Disease
(March 22, 2017) – U.S. regulators have approved the first new drug in a decade for Parkinson’s disease, The Food and Drug Administration has approved Xadago for use when a patient’s regular medicines aren’t working well. Newron Pharmaceuticals develop …
-
Cancer Drug That Might Slow Parkinson
(March 15, 2017) – Scientists are hoping that nilotinib, a drug approved to treat a form of leukemia, can treat two devastating brain diseases: Parkinson’s and Alzheimer’s. In late 2015, researchers at Georgetown University Medical Center found that sm …
-
The 23rd Parkinson’s Unity Walk to Take Place on Saturday, April 22nd in New York City’s Central Park
Largest grassroots event to raise funds and unite the community in the battle to eradicate Parkinson’s diseaseKINGSTON, N.J. (March 6, 2017) — The Parkinson Alliance announced today that the 23rd Parkinson’s Unity Walk will …
-
Study Shows Link Between Microbiome in the Gut and Parkinson
(March 3, 2017) – There is growing evidence showing a connection between Parkinson’s disease and the composition of the microbiome of the gut. A new study from researchers at the University of Alabama at Birmingham shows that Parkinson’s disease, and m …